...
首页> 外文期刊>Virchows Archiv >Systemic Erdheim–Chester disease
【24h】

Systemic Erdheim–Chester disease

机译:系统性Erdheim–Chester病

获取原文
获取原文并翻译 | 示例

摘要

Erdheim–Chester disease is a rare xanthomatosis that may present with characteristic radiologic and histologic features. There have been conflicting reports regarding the nature of this process, including whether it represents a reactive or neoplastic lesion. We present the clinical histories, pathologic findings, and an analysis of clonality using the HUMARA assay in two patients diagnosed with Erdheim–Chester disease. One case has previously been documented in the literature. Histologically, both cases demonstrated sheets of foamy xanthomatous histiocytes with widespread infiltration of the viscera. These regions were punctuated by variable amounts of inflammation, including lymphocytes, plasma cells, and occasional Touton-type giant cells. The histiocytes were immunoreactive for CD68 and CD163; they did not stain with S100 or CD1a. One case was found to be monoclonal; however, the second case had extensive DNA degradation; thus, clonality could not be assessed. In addition to contributing an additional report of this rare disease to the literature, we demonstrate the histiocytes to express CD163, thereby further supporting a monocyte/macrophage basis. Moreover, in confirming clonality, our observations lend additional evidence to the view that Erdheim–Chester disease represents a neoplastic process.
机译:Erdheim–Chester病是一种罕见的黄瘤病,可能表现为放射学和组织学特征。关于该过程的性质,包括它是否代表反应性或赘生性病变,一直有相互矛盾的报道。我们介绍了两名诊断为Erdheim–Chester病的患者的临床历史,病理发现以及使用HUMARA分析进行的克隆性分析。以前在文献中已经记录了一个案例。从组织学上讲,这两种情况均显示出泡沫状黄瘤组织细胞片,内脏广泛浸润。这些区域被可变数量的炎症击穿,包括淋巴细胞,浆细胞和偶有的Touton型巨细胞。组织细胞对CD68和CD163具有免疫反应性。他们没有被S100或CD1a染色。发现一例是单克隆的。然而,第二例DNA大量降解。因此,无法评估克隆性。除了为文献报道这种罕见疾病的报道外,我们还证明了组织细胞表达CD163,从而进一步支持了单核细胞/巨噬细胞。此外,在确认克隆性方面,我们的观察结果进一步证实了Erdheim–Chester病是一种肿瘤形成过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号